• 제목/요약/키워드: Radioactive iodine

검색결과 188건 처리시간 0.025초

Radioactive Seed Implantation and Lobaplatin Chemotherapy Are Safe and Effective in Treating Patients with Advanced Lung Cancer

  • Li, Jia-Rui;Sun, Yu;Liu, Lin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권9호
    • /
    • pp.4003-4006
    • /
    • 2015
  • Objecive: To investigate the clinical safety and efficacy of CT-guided $^{125}iodine$ (125I) seed implantation combined with percutaneous intra-tumor injection of chemotherapy emulsion of lobaplatin and lipiodol in treating patients with advanced lung cancer. Materials and Methods: Patients with advanced lung cancer and treated with spiral CT-guided $^{125}I$ seed implantation combined with percutaneous intra-tumor injection of chemotherapy emulsion of lobaplatin and lipiodol were recruited. Results: Of the 36 patients, there were 40 nidi in total. The contrast-enhanced CT evaluation was conducted 60 d after treatment. Response evaluation suggested that 4 patients achieved complete remission (CR), 24 partial remission (PR), 4 stable disease (SD) and 4 progression disease (PD), with a total response rate of 77.8% (28/36). Conclusions: CT-guided $^{125}I$ seed implantation combined with percutaneous intra-tumor injection of chemotherapy emulsion of lobaplatin and lipiodol are safe and effective in treating patients with advanced lung cancer.

갑상선 역형성암종 (Anaplastic Carcinoma of Thyroid Gland)

  • 이원종;심윤상;오경균;이용식
    • 대한기관식도과학회지
    • /
    • 제1권1호
    • /
    • pp.151-158
    • /
    • 1995
  • Anaplastic carcinoma of thyroid gland account for no more than 10% of thyroid cancer, but it shows extremely poor prognosis. The purpose of this study is to review the outcome of patients with anaplastic carcinoma over the span of 5 years and to determine the patterns of clinical presentation, age, sex and other possible prognostic variables. We analyzed 30 cases of anaplastic carcinoma retrospectively from 1991 to 1995. There were 14 men and 16 women. There age ranged 33 to 75 years with a mean of 61.0 years. Sixteen patients presented with transformationqr of well differentiated carcinoma to anaplastic carcinoma, 1 with rapid in-crease in the size of long standing goiter, 8 with rapidly growing neck mass and 4 with meta static disease. Twenty-eight patients(93.3%) showed cervical lymphnode metastasis at presentation and twenty three patients(76.6%) showed laryngotracheal invasion. Nine patients (30.3%) showed distant metastasis. Treatment modalities included surgical resection, external irradiation, radioactive iodine and systemic chemotherapy. At decision making of treatment plan, we considered completeness of initial surgery, uptake rate of whole body radioactive io-dine scan, locoregional progression and distant metastasis. The median survival was 6.8 months and three cases survived beyond 12 months.

  • PDF

활성알루미나를 이용하여 방사성 폐수 중 I-와 IO3-를 제거하는 방법 (Removal of I- and IO3- from Aqueous Solution)

  • 임헌성;이석근
    • 분석과학
    • /
    • 제22권6호
    • /
    • pp.519-523
    • /
    • 2009
  • 본 연구는 수용액 중에 존재하는 방사성 동위원소인 요오드 즉, 요오드이온($I^-$), 요오드산이온(${IO_3}^-$)및 요오드($I_2$)를 효과적으로 제거하는 방법에 관한 것이다. 별도로 물리적 화학적 변화의 과정이 필요하지 않고, 표면 개질된 활성 산화알루미늄과 활성탄을 이용하여 완전하게 제거할 수 있어 방사성 폐수 및 일반 산업폐수에도 유용하게 적용될 수 있다. 요오드이온($I^-$), 요오드산이온(${IO_3}^-$)의 혼합수용액 중의 각 이온들을 은 처리된 염기성 알루미나와 산성 알루미나를 이용한 흡착제거 방법으로 각각 99% 이상 제거하는 효과를 나타내었다.

방사성이온으로 오염된 물의 역삼투막공정을 이용한 이온제거 (Ions Removal of Contaminated Water with Radioactive Ions by Reverse Osmosis Membrane Process)

  • 신도형;정성일;임지원
    • 멤브레인
    • /
    • 제26권5호
    • /
    • pp.401-406
    • /
    • 2016
  • 본 연구에서는 역삼투막공정을 이용하여 수용액 중 저준위 방사성이온인 세슘과 요오드 이온을 제거하는 실험을 수행하였다. 국내에서 생산되는 역삼투막모듈 두 가지와 그리고 폐모듈 세정한 후 세슘과 요오드 이온에 대한 제거성능을 비교하였다. 공급수의 농도와 압력을 달리하여 실험을 진행한 결과, 세 가지 모듈 모두 세슘에 비해 요오드의 제염계수가 높은 것을 알 수 있었으며, 특히, 세정한 모듈은 요오드에 대한 제염계수가 1140으로 확인되었다. 대체적으로 실험조건이 고압일 때보다 저압일 때 제염성능이 좋은 것으로 나타났으며 이는 저압조건에 가까운 압력을 갖는 수도수에 직접 모듈을 설치할 경우에도 사용이 가능하리라 판단되었다. 또한 EDTA와 SBS, NaOH, 마이크로버블 등을 사용하여 세정한 막의 제염성능이 세정 전의 제염성능보다 높아졌으며 저압, 저농도 조건에서 요오드에 대한 회수율이 세정 후에 6.3% 증가한 결과를 얻었다.

갑상샘 여포암의 다발성 골전이 1예 (Follicular Thyroid Cancer with Multiple Bone Metastasis : A Case Report)

  • 사대진;곽슬기;김승우
    • 대한두경부종양학회지
    • /
    • 제28권2호
    • /
    • pp.143-145
    • /
    • 2012
  • Follicular thyroid cancer(FTC) accounts for about 10-15% of thyroid cancer. Distant metastasis is common, usually to lung, bone and brain. 71-years-old man visited neurosurgery outpatient department. He complained of recent 6kg weight loss, left upper extremity pain with weakness and back pain. The radiologic findings showed multiple bone metastasis including thoracic spine and left scapular resulting from FTC. There was a probable brain metastatic lesion on right temporal fossa. The core biopsy of thyroid and thoracic spine(T11) confirmed metastatic follicular carcinoma. Radioactive iodine therapy and radiotherapy was done following total thyroidectomy. We report a unique case of multiple bone metastasis from follicular carcinoma of thyroid with literature review.

Graves병 갑상선 기능항진증에서 방사성 옥소 치료의 지견 (Current Opinions on the Radioiodine Treatment of Graves' Hyperthyroidism)

  • 이상우;이재태
    • 대한핵의학회지
    • /
    • 제37권6호
    • /
    • pp.341-354
    • /
    • 2003
  • Radioactive iodine therapy using I-131 for hyperthyroidism has been used for more than 50 years, and generally considered safe and devoid of major side effects. Appropriate patient selection criteria and clinical judgement concerning patient preparation should be employed for its optimal use. It has not been possible to resolve the trade-off between efficient definite cure of hyperthyroidism and the high incidence of post-therapy hypothyroidism. The dose of the I-131 needed to maintain euthyroid state remains an area of uncertainity and debate. Early side effects are uncommon and readily managable. Other than the need for long-term monitoring and, in most cases, lifelong thyroid hormone treatment for late adverse consequences of this treatment remains only conjectural. We have reviewed general principles and recent advances in radioiodine treatment for Graves' hyperthyroidism, specially regarding to several controversies.

흉곽내 갑상선종 1예 보고 (Intrathoracic Goiter)

  • 김용환
    • Journal of Chest Surgery
    • /
    • 제22권6호
    • /
    • pp.1056-1060
    • /
    • 1989
  • Substernal goiter may be defined as any thyroid enlargement that has 50 to 100 % of its mass inferior to the thoracic inlet. Ectopic substernal goiters are rare, and most substernal gaiters arise from cervical thyroid gland. Fifteen to fifty percent of these patients are asymptomatic. Symptoms, when present, are usually the result of tracheal or esophageal compression. Symptoms are often positional. Standard chest roentgenograms are often diagnostic, but computed tomographic or radioactive iodine scans may be helpful. In symptomatic patients or those in whom explorations are undertaken for diagnostic purpose or exclude carcinoma, surgical removal is indicated. Although cervical thyroids with substernal extension may be safely and successfully removed through a cervical incision, primary substernal goiters by definition derive their blood supply from within the thorax and are better approached by splitting the sternum or through a posterolateral thoracotomy. Recently we experienced a child fist sized secondary posterior mediastinal goiter in 55-year old female. The mass was completely removed through right posterolateral thoracotomy without any complications. The postoperative courses were uneventful.

  • PDF

경부 악성 림프종과 동반된 유두상 갑상선암 (Synchronous Presentation of Papillary Thyroid Cancer and Malignant Lymphoma)

  • 장항석;정웅윤;박정수
    • 대한두경부종양학회지
    • /
    • 제14권2호
    • /
    • pp.253-259
    • /
    • 1998
  • The increasing risk of subsequent malignancy after treatment of malignant lymphoma is well known, which is mainly due to longer survival of these patients. Radiotherapy at an early stage of Hodgkin's disease or non-Hodgkin's lymphoma is accepted to be associated with future occurrence of secondary thyroid cancer. Nevertheless, the synchronous presentation of these malignancies is extremely rare. Well differentiated thyroid cancer, a slow-growing tumor that responds to therapy with surgery and radioactive iodine, is associated with prolonged survival. therefore, it is important to make this diagnosis in patients who show evidence of malignant lymphoma. Furthermore, appropriate treatment must be considered for thyroid cancer to improve the prognosis of these patients. We herein reported 4 cases of synchronous thyroid cancer and malignant lymphoma in patients who had not previously recieved radiotherapy or chemotherapy.

  • PDF

유두상 갑상선 암의 척추전이 1예 (A Case of Thyroid Papillary Cancer with Spinal Metastasis)

  • 양석민;장재원;신유섭;김철호
    • 대한두경부종양학회지
    • /
    • 제29권2호
    • /
    • pp.79-82
    • /
    • 2013
  • Thyroid cancer is known as its relatively high cure rate after surgical treatment and spinal metastasis of thyroid cancer is extremely rare as the prevalence is only 2-13%. Spinal metastasis is usually asymptomatic and discovered incidentally in most cases. A 66-year-old man was diagnosed as thyroid papillary cancer with spinal metastasis. We treated the patient by surgery, adjuvant radiotheraphy and radioactive iodine therapy. C6 corpectomy was followed for the residual spinal metastasis by the department of neurosurgery. The patient had no functional complication by the surgical process. At 24 months after surgery, there was no sign of recurrence and the patient led social life without any discomfort. We present this case with a review of the related literatures.